Pentoxifylline

己酮可可碱

Report date: 2026/03/31 20:00:21

Base Information

Drug NamePentoxifylline
Drug Alias NamePentoxifilina已酮可可豆碱Oxpentifylline循能泰活脑灵 +[22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphoric diester hydrolases inhibitors
TargetsPhosphoric diester hydrolases
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorDepressive Disorder +[45
Global Approved IndicationsPeripheral Vascular DiseasesPeripheral arterial occlusive disorders
Approved Indications in ChinaPeripheral Vascular Diseases
Original Approved Country/TerritoryFrance
Original Approved Date1980/10/19
Country/TerritoryCanadaUnited StatesEgypt +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi-Aventis Sa
China Registration ClassN/A

Develop Information

Active IndicationsDepressive DisorderBipolar DisorderVascular Calcification +[16
Inactive IndicationsSchizophreniaDepressive Disorder, MajorDepression +[29

Other Information

ATC CodeC04AD03